FindTrial
Sign In

Application of blood derived proteins in management of gum tissue loss between teeth

Clinical efficacy of injectable platelet rich fibrin (I-Prf) in management of interdental papillary loss â?? A prospective observational case series

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/08/044915
Enrollment
25
Registered
2022-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K060- Gingival recession

Interventions

Intervention1: Group1: Injectable Platelet Rich Fibrin (i-PRF): 10cc of peripheral blood will be procured and centrifuged at 700RPM for 3 minutes to prepare injectable platelet rich fibrin. Using micr

Sponsors

DrAnupama Tadepalli
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Class I, Class II interdental papillary loss based on Norland and Tarnowâ??s classification 2. Papillary recession in the maxillary anterior teeth and premolars 3. No active periodontal diseases (Probing pocket depth 4. Sites with minimum width of Keratinised gingiva( >1mm)

Exclusion criteria

Exclusion criteria: 1. Patients with inadequate plaque control 2. Platelets count less than one lakhs per cubic mm. 3. Teeth with prosthetic restorations 4. Smokers 5. Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To assess the mean changes in papillary heightTimepoint: Baseline and 3 months—

Secondary

MeasureTime frame
1. To assess the papillary fill using inter proximal gingival index (Jemt score) 2. To assess patient perception by using VAS esthetic scale. Timepoint: Baseline and 3 months—

Countries

India

Contacts

Public ContactAnupama Tadepalli

SRM Dental College

anupamamds@gmail.com09677065517

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026